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Pathogenicity of methicillin-resistant Staphylococ-
cus aureus (MRSA) is directly associated with a broad 
spectrum of virulence factors, amongst which is 
α-hemolysin (i.e. HIa or α-toxin). It is generally con-
sidered that α-hemolysin plays a central role in the 
pathogenesis of staphylococcal infections, especially 
in pulmonary infections caused by these bacteria 
(Bubeck Wardenburg et al., 2007; Burlak et al., 2007; 
Montgomery et al., 2008). Approximately one half of 
staphylococcal necrotizing pneumonia cases affect-
ing previously healthy adults and children are caused 
by community-associated MRSA strains (Ragle and 
Bubeck Wardenburg, 2009). Besides direct lysis of the 
pulmonary cells, α-hemolysin also activates alveolar 
macrophages or monocytes, induces massive polymor-
phonuclear leukocyte influx into lung parenchyma with 
subsequent degranulation and destruction of microvas-
cular endothelium and adjacent tissues, and induces 
platelet-neutrophil co-aggregation leading to the host 
response to toxin that contribute to the severity of 
lung destruction (Parimon et al., 2013). Such complex 
pathogenicity and occurrence of multiresistant strains 
urge the development of antimicrobial compounds that 
selectively target virulence factors. In past years, several 
studies investigated the inhibitory activity of various 
compounds against extracellular virulence factors of 
S. aureus (Escaich, 2008; Cegelski et al., 2008). Previously 
we have reported antimicrobial activity of three newly-
synthesized chalcones against clinical isolates of MRSA, 
and inhibitory effect on the expression of virulence 
factors related to the early step of bacterial invasion-
adherence (i.e. biofilm formation, glycocalyx produc-
tion and adherence to human fibronectin) (Božić et al., 
2014). Therefore, the aim of this study was to investigate 
the effect of 1,3- Bis-(2-hydroxy-phenyl)-propenone 
(O-OH), 3-(3-Hydroxy-phenyl)-1-(2-hydroxy-phenyl)-
propenone (M-OH) and 3-(4-Hydroxy-phenyl)-1-(2-
hydroxy-phenyl)-propenone (P-OH) on α-hemolysin 
production of clinical isolates of multiresistant and 
genetically diverse strains of MRSA. 
Antibacterial activity of chalcones was tested against 
20 clinical isolates of MRSA isolated from blood (4), 
wound (6), sputum (3), endotracheal tube (2), abdomi-
nal drain (1), nose (1), skin (1), urine (1) and external 
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A b s t r a c t
Pathogenicity of methicillin-resistant Staphylococcus aureus (MRSA) is associated with a broad spectrum of virulence factors, amongst 
which is α-hemolysin. The aim of this study was to investigate the effect of three newly-synthesized chalcones (1,3- Bis-(2-hydroxy-phenyl)-
propenone, 3-(3-Hydroxy-phenyl)-1-(2-hydroxy-phenyl)-propenone and 3-(4-Hydroxy-phenyl)-1-(2-hydroxy-phenyl)-propenone) on 
α-hemolysin production of clinical isolates of MRSA. Subinhibitory concentrations of the tested compounds reduced hemolytic activity 
of MRSA strains, with almost complete abolishment of hemolysis at concentrations in the range of 1/2–1/4 x MIC (25–12.5 μg/ml). In 
conclusion, newly-synthesized chalcones tested in this study showed potent inhibitory activity on α-hemolysin production of multiresistant 
and genetically diverse MRSA strains.
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auditory canal (1) and one laboratory control strain of 
methicillin-resistant S. aureus ATCC 43300 (KWIK-
STIKTM, Microbiologics, USA). Identification of the 
isolates and methicillin resistance were determined by 
VITEK 2 test cards GP and AST-P580 (bioMérieux, 
France) and confirmed by PCR for nuc (Brakstad et al., 
1992) and mecA (Bignardi et al., 1996) genes. Genotyp-
ing (SCCmec, agr, pvl and spa typing) of MRSA was 
performed according to previously described proto-
cols (Boye et al., 2007; Lina et al., 2003; Harmsen et al., 
2003). The spa types were clustered into spa clonal com-
plexes (CCs) using the algorithm based upon repeat 
pattern (BURP) with Ridom Staph-Type 1.4 software 
(http://www.ridom.de). The multiresistance profile of 
MRSA strains was determined by VITEK 2 test card 
AST-P580 and further supplemented with disc diffu-
sion test according to CLSI guidelines (CLSI, 2007). 
Chalcones tested in this study (Fig. 1) were obtained 
from the Department of Pharmaceutical Chemistry, 
University of Belgrade-Faculty of Pharmacy, Belgrade, 
Serbia. Compounds were prepared and characterized 
as previously described (Božić et al., 2014) and their 
antimicrobial activity was determined by broth micro-
dilution test according to CLSI guidelines (CLSI 2007). 
Hemolytic activities of MRSA culture supernatants 
were determined according to the method of Rowe 
and Welch (1994). The data obtained in this study were 
analyzed in SPSS statistical program (PASW statistics 
for Windows, Version 18.0, Chicago: SPSS Inc. USA) 
using methods of descriptive statistics, Chi square test 
and Mann-Whitney U test.
Clinical isolates of MRSA were genetically het-
erogeneous and expressed multiresistance phenotype 
(Table  I). MRSA strains were classified into SCCmec 
type I (55.5%), II (5.0%), III (20.0%), IV (10.0%) and 
V  (10.0%) and agr type I (35.0%), II (60.0%) and 
III (5.0%). Strains belonged to 10 spa types and were 
clustered into 5 spa CCs, with most frequent CC5 
(55.0%) and CC8 (20.0%).
Tested chalcones exerted inhibitory activity against 
MRSA, with the order of potency of chalcones (aver-
age MIC ± SD) as following: O-OH (MIC = 37.5 ± 
13.2 μg/ml) > M-OH (MIC = 97.5 ± 27.5 μg/ml) > P-OH 
(MIC = 110.8 ± 21.1 μg/ml). The most significant dose-
dependent inhibition of hemolysis was observed in 
MRSA supernatants cultivated with O-OH chalcone 
(Fig. 2). A  91.6–99.7% reduction of hemolysis was 
detected in all MRSA strains cultivated with ½ × MIC 
of O-OH. Hemolytic activity of MRSA strains cultivated 
with 1/2 × MIC (25.0 µg/ml) and 1/4 × MIC (12.5 µg/ml) 
of O-OH was in the range of 3.8–8.2% of the positive 
control (p < 0.001). Mild increase of the hemolytic 
activity was detected after cultivation with 1/8 × MIC 
(6.2 µg/ml) up to 19% (p < 0.01), and 1/16 × MIC 
(3.1 µg/ml) up to 34.6% (p < 0.01). The effect of M-OH 
Fig. 1. The chemical structures of the tested chalcones:
1,3- Bis-(2-hydroxy-phenyl)-propenone (O-OH) 
3-(3-hydroxy-phenyl)-1-(2-hydroxy-phenyl)-propenone (M-OH)
3-(4-hydroxy-phenyl)-1-(2-hydroxy-phenyl)-propenone (P-OH)
CC5 t041 9 1 2 – AM, GEN, KAN, TOB, STR, LIN, CLIN, ER, CLA, AZ, SPIRA, TET, DOX, CHL
 t041 1 1 1 – AM, GEN, KAN, TOB, STR, LIN, CLIN, ER, CLA, AZ, SPIRA, CHL
 t003 1 2 2 – KAN, TOB, LIN, CLIN, ER, CLA, AZ, SPIRA
CC8 t030 2 3 1 – AM, GEN, KAN, TOB, STR, ER, CLA, AZ, TET, DOX, MIN, CHL
 t030 1 3 2 – AM, GEN, KAN, TOB, STR, LIN, CLIN, ER, CLA, AZ, SPIRA, TET, DOX, MIN
 t969 1 3 1 – AM, GEN, KAN, TOB, STR, ER, CLA, AZ, TET, DOX
CC45 t015 1 1 2 – AM, GEN, KAN, TOB, STR, LIN, CLIN, ER, CLA, AZ, SPIRA, CHL
 t583 1 4 1 – AM, GEN, KAN, TOB, STR, ER, CLA, AZ
CC80 t044 1 4 3 + KAN, STR, TET
CC152 t595 1 5 1 + GEN, KAN, TOB, LIN, TET
 t6371 1 5 1 – GEN, KAN, TOB, ER, CLA, AZ
Table I
Genotyping and resistance profiles of MRSA strains.
AM – amikacin, GEN – gentamicin, KAN – kanamycin, TOB – tobramycin, STR – streptomycin, LIN – lincomycin, CLIN – clindamycin,
ER – erythromycin, CLA – clarithromycin, AZ – azithromycin, SPIRA – spiramycin, TET – tetracycline, DOX – doxycycline,
MIN – minocycline, CHL – chloramphenicol.
CC
type
spa
type
N° of
strains
SCCmec
type
agr
type PVL Resistance profile (> 50% of strains)
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and P-OH was tested in the two-fold higher con-
centrations than O-OH chalcone (50.0–6.2 µg/ml), 
corresponding the same range of MIC’s (1/2 × MIC 
–  1/16 × MIC). Hemolytic activity of MRSA strains 
cultivated with 1/2 × MIC and 1/4 × MIC of M-OH 
was in the range of 7.1–18.8% of the positive control 
(p < 0.01; p < 0.001), and cultivation with 1/8 × MIC 
lead to the increase of the hemolysis up to 40.7% of 
the positive control (p < 0.05). The lowest applied con-
centration of M-OH (1/16 × MIC, 6.2 µg/ml) did not 
reduce the hemolytic activity of MRSA (p > 0.05). Sta-
tistically significant inhibition of hemolytic activity of 
MRSA strains cultivated with P-OH chalcone occurred 
only in concentrations of 1/2 × MIC (7.7%; p < 0.01) 
and 1/4 × MIC (43.8%; p < 0.05) (Fig. 2). Chalcones 
themselves did not perform any hemolytic activity or 
induced hemolysis of rabbit erythrocytes in the same 
range of MIC’s (1/2 × MIC – 1/16 × MIC; p > 0.05).
Antistaphylococcal activity of various chalcones is 
strongly correlated with their chemical characteristics. 
It is generally considered that lipophilicity of the ring A 
(Nowakowska, 2007) and presence of free hydroxyl 
group/s at various positions of the ring B are necessary 
for antistaphylococcal activity of these compounds (Sato 
et al., 1996; Alcaraz et al., 2000; Kromann et al., 2004; 
Talia et al., 2011). Three compounds investigated in our 
study carrying free hydroxyl group at various positions 
of the B ring exerted strong anti-MRSA activity, with 
1,3- Bis-(2-hydroxy-phenyl)-propenone (O-OH) bear-
ing the hydroxyl group at the position 2 of ring B as the 
most active one. These results are in accordance with 
the findings of other investigators (Alcaraz et al., 2000; 
Kromann et al., 2004). Subinhibitory concentrations of 
the tested compounds also inhibited hemolytic activ-
ity of MRSA strains in a dose dependent manner, with 
almost complete abolishment of hemolysis at concen-
trations in the range of 1/2–1/4 MIC (25–12.5 μg/ml). 
Inhibition of hemolytic activity of α-hemolysin was 
dose dependent. Chalcone with free hydroxyl group at 
the position 2 of ring B was the most active one, since 
the lowest applied concentration of this compound 
(1/16 × MIC, 3.1 µg/ml) exerted statistically significant 
inhibition of hemolysis. Higher concentrations of other 
tested compounds exerted similar inhibitory effect, 
with partial or complete recovery of hemolytic activity 
of α-hemolysin when applied in the lowest concentra-
tions (1/16 × MIC, 6.2 µg/ml). Previously it has been 
reported that subinhibitory concentrations of chalcones 
with similar chemical structure isolated from natural 
sources, like licochalcone A and E, inhibit α-hemolysin 
production (Qiu et al., 2010a; Zhou et al., 2012). Lico-
chalcone A possess anti-MRSA activity in the range of 
MIC’s from 2.0–8.0 µg/ml (Fukai et al., 2002; Qiu et al., 
2010a), and inhibitory effect on α-hemolysin produc-
tion in the range of 1/2–1/8 × MIC (Qiu et al., 2010a). 
Licochalcone E was found to be the most active lico-
chalcone against S. aureus, since the inhibitory effect 
was detected in the range of MIC’s from 1.0–4.0 µg/ml, 
and inhibition of α-hemolysin production in the range 
of 1/4–1/16 × MIC (Zhou et al., 2012).
Precise mechanism of antimicrobial activity of chal-
cones and inhibition of α-hemolysin synthesis has not 
been clarified yet. Several different mechanisms could 
be involved, like direct enzyme inhibition, inhibition 
Fig. 2. The inhibitory effect of the O-OH, M-OH and P-OH chalcone on α-hemolysin production of MRSA strains.
Results are present as mean percent of hemolysis ± SD of 20 clinical isolates of MRSA and one control strain (MRSA ATCC 43300),
compared to the positive control (i.e. hemolytic activity of supernatants of untreated MRSA strains presented as 100% hemolysis);
* p < 0.05; ** p < 0.01; *** p < 0.001.
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of DNA or RNA synthesis (Mori et al., 1987; Ohemeng 
et al., 1993) or interference with energy metabolism by 
inhibition of NADH-cytochrome c reductase, reducing 
the energy required for active uptake of various meta-
bolites and biosynthesis of macromolecules (Haraguchi 
et al., 1998; Cushnie and Lamb, 2011). Licochalcone A 
(Qiu et al., 2010a) or thymol (Qiu et al., 2010b) perform 
inhibitory effect on α-hemolysin synthesis through 
inhibition of agrA transcription, one of the components 
of the agr global regulatory system of S. aureus. Besides 
influence on agr global regulatory system, licochalcone 
E also directly inhibits expression of hla-gene encoding 
α-hemolysin synthesis (Zhou et al., 2012). Accordingly, 
it is possible that chalcones also inhibit production of 
α-hemolysin through mechanisms proposed by Qui 
et al. and Zhou et al. Further studies are necessary to 
elucidate the precise mechanisms of inhibitory effect of 
tested chalcones on hemolytic activity of α-hemolysin.
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